Novartis India Limited (BOM:500672)

Novartis India Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	1,009	851.9	1,034	-37.2	209
Depreciation & Amortization	21.9	26.1	60.6	96.5	121.6
Loss (Gain) From Sale of Assets	-1.1	-32.1	-28.9	1.4	-45.5
Stock-Based Compensation	3.3	2.5	3.8	18.5	17.4
Provision & Write-off of Bad Debts	-1.7	1.7	3.7	-3.6	1
Other Operating Activities	-278.1	193.5	-384.8	-356.1	-304.8
Change in Accounts Receivable	15	-53.4	80.3	-42	-9.2
Change in Inventory	37.5	98.6	23.5	-91.2	107.3
Change in Accounts Payable	-92.5	21.2	-100.2	148.3	-173.8
Change in Other Net Operating Assets	32.4	24	-243.6	652.1	-615.1
Operating Cash Flow	745.7	1,134	448	386.7	-692.1
Operating Cash Flow Growth	-34.24%	153.13%	15.85%	-	-
Capital Expenditures	-	-	-3.1	-5	-0.9
Sale of Property, Plant & Equipment	3.2	32.7	39.4	-	46.8
Investment in Securities	-449	-48.3	-1,769	720	697.9
Other Investing Activities	412.7	346.9	199.8	155.4	207.8
Investing Cash Flow	-33.1	331.3	-1,533	870.4	951.6
Long-Term Debt Repaid	-24.1	-37	-57.4	-109	-120.3
Net Debt Issued (Repaid)	-24.1	-37	-57.4	-109	-120.3
Common Dividends Paid	-617.3	-1,173	-246.9	-246.9	-246.9
Other Financing Activities	-0.1	-0.1	-0.5	-0.4	-0.8
Financing Cash Flow	-641.5	-1,210	-304.8	-356.3	-368
Net Cash Flow	71.1	255.4	-1,389	900.8	-108.5
Free Cash Flow	745.7	1,134	444.9	381.7	-693
Free Cash Flow Growth	-34.24%	154.89%	16.56%	-	-
Free Cash Flow Margin	20.93%	33.84%	11.75%	9.55%	-18.17%
Free Cash Flow Per Share	30.20	45.93	18.02	15.46	-28.07
Cash Interest Paid	0.1	0.1	0.5	0.4	0.8
Cash Income Tax Paid	162.9	-382.7	-23.4	185.9	351.9
Levered Free Cash Flow	484.19	498.14	568.16	1,205	-491.56
Unlevered Free Cash Flow	489	507.45	579.1	1,236	-443.56
Change in Working Capital	-7.6	90.4	-240	667.2	-690.8

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.